These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 8448747

  • 21. Renal complications of intravesical bacillus Calmette-Guérin therapy.
    Modesto A, Marty L, Suc JM, Kleinknecht D, de Frémont JF, Marsepoil T, Veyssier P.
    Am J Nephrol; 1991; 11(6):501-4. PubMed ID: 1819218
    [Abstract] [Full Text] [Related]

  • 22. A randomized study of intravesical mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder.
    Vegt PD, Witjes JA, Witjes WP, Doesburg WH, Debruyne FM, van der Meijden AP.
    J Urol; 1995 Mar; 153(3 Pt 2):929-33. PubMed ID: 7853577
    [Abstract] [Full Text] [Related]

  • 23. Clinical and pathological findings in prostates following intravesical bacillus Calmette-Guerin instillations.
    Mukamel E, Konichezky M, Engelstein D, Cytron S, Abramovici A, Servadio C.
    J Urol; 1990 Dec; 144(6):1399-400. PubMed ID: 2231934
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Granulomatous renal mass after treatment with intravesical bacille Calmette-Guérin.
    Rocha Mde S, Campagnari JC.
    AJR Am J Roentgenol; 1994 Oct; 163(4):996-7. PubMed ID: 8092061
    [No Abstract] [Full Text] [Related]

  • 27. Case report: renal granuloma following intra-vesical bacillus Calmette-Guerin.
    Goh PY, Htoo MM, Yeong KY.
    Clin Radiol; 1996 Jan; 51(1):69-72. PubMed ID: 8549054
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.
    Arends TJ, Nativ O, Maffezzini M, de Cobelli O, Canepa G, Verweij F, Moskovitz B, van der Heijden AG, Witjes JA.
    Eur Urol; 2016 Jun; 69(6):1046-52. PubMed ID: 26803476
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin.
    Soylu A, Ince AT, Polat H, Yasar N, Ciltas A, Ozkara S, Tasci AI.
    Ann Clin Microbiol Antimicrob; 2009 Apr 15; 8():12. PubMed ID: 19368735
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Miliary tuberculosis secondary to transurethral bacillus Calmette-Guérin administration for superficial transitional cell carcinoma of the bladder.
    Skoutelis A, Melekos MD, Bassaris HJ.
    J Natl Cancer Inst; 1990 Jul 18; 82(14):1219-20. PubMed ID: 2362292
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Intravesical immunotherapy of in situ carcinoma of the urinary bladder using Bacillus Calmette-Guerin (BCG)].
    Jakse G.
    Wien Klin Wochenschr; 1987 Feb 20; 99(4):114-8. PubMed ID: 3577186
    [Abstract] [Full Text] [Related]

  • 40. [Treatment of superficial tumors of the bladder with bacillus Calmette-Guérin].
    Ackermann D, Schnyder M, Bandelier D, Studer UE.
    J Urol (Paris); 1986 Feb 20; 92(1):33-8. PubMed ID: 3722851
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.